Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event-Reference-Cited by-同舟云学术

Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event

Published:2013-02 Issue:1 Volume:163 Page:102-104
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Vervueren Paul-Louis,Elbaz Meyer,Dallongeville Jean,Arveiler Dominique,Ruidavets Jean-Bernard,Montaye Michèle,Wagner Aline,Amouyel Philippe,Haas Bernadette,Bongard Vanina,Ferrières Jean

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N Engl J Med,1996

2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group;N Engl J Med,1998

3. Effects of statins beyond lipid lowering: potential for clinical benefits;Almuti;Int J Cardiol,2006

4. Statins for the primary prevention of cardiovascular disease;Taylor;Cochrane Database Syst Rev,2011

5. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study;Spencer;Ann Intern Med,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of statin pretreatment with presentation characteristics, infarct size and outcome in older patients with acute coronary syndrome: the Elderly ACS-2 trial;Age and Ageing;2022-06-01

2. Pitavastatin: Coronary Atherosclerotic Plaques Changes and Cardiovascular Prevention;High Blood Pressure & Cardiovascular Prevention;2022-01-22

3. The State of the Problem of Achieving Extremely Low LDL Levels;Current Pharmaceutical Design;2021-10

4. Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome;Theranostics;2021

5. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel;European Heart Journal;2020-02-13